The Fresenius Medical Care Foundation has awarded a $125,000 grant to the American Society of Transplantation (AST) to survey organ transplant recipients about their experiences with current immunosuppressant agents. Insights gained from the survey will inform strategies to improve patient-reported outcomes.
The survey is designed to pinpoint and address unmet patient needs associated with immunosuppressive medications for people who have undergone organ transplantation. By offering transplant recipients the opportunity to share their experiences with anti-rejection medications, the survey aims to spur patient-centered innovation in immunosuppressive treatments that are centered around the patient's perspective.
“We are proud to partner with the American Society of Transplantation on this initiative to integrate patient voices into the next frontier of post-transplant treatments,” said Benjamin Hippen, MD, FASN, FAST, Fresenius Medical Care’s Head of Transplant Medicine and Emerging Capabilities and Advisory Committee Member for the Foundation. “Supporting methodologically sound patient-reported outcomes research builds on our commitment to help patients, their families and communities most impacted by renal disease.”
The donation supports the Foundation’s focus of raising awareness of kidney disease and transplantation as a lifesaving solution. The Foundation is transforming the kidney disease community by working in collaboration with leading organizations in kidney disease and transplantation.
It’s because of you and your generous support that together we can support the American Society of Transplantation, as well as:
the National Kidney Foundation to grow their pilot initiative – Big Ask: Big Give – into fifteen new markets
DonateLife America to help them build and expand the inaugural Living Donor Registry
United Network of Organ Sharing (UNOS) to research topics connected to organ transport, tracking and logistics; and
UNOS to study the relationship between race/ethnicity and social determinants of health in post-transplant outcomes.
If you are inspired by this work, please consider a donation to support our investments in transplantation. Click here to make a tax-deductible contribution.